There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research ...

CAMBRIDGE, Mass., November 04, 2024--2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held ...

Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received an average rating of “Moderate Buy” from the nine ...

Updating on the latest Abecma sales, 2seventy bio said Q3 revenue growth for the drug in the U.S. is expected to reach roughly 30% from Q2’s $54M revenue.New patient starts for Q3 are also ...

Exchange Traded Concepts LLC lowered its holdings in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 36.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 34,816 shares of the ...

On September 25, 2024, 2seventy bio issued a press release announcing that it "will discontinue enrollment in its ongoing Phase 3 KarMMa-9 study evaluating Abecma® (idecabtagene vicleucel ...

NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of 2seventy bio, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with study sponsor Bristol Myers Squibb (BMS), will discontinue enrollment in ...

TD Cowen analyst Yaron Werber maintained a Hold rating on 2seventy bio (TSVT – Research Report) today. The company’s shares closed ...

Short interest in 2seventy bio Inc (NASDAQ:TSVT) increased during the last reporting period, rising from 5.13M to 5.32M. This put 12.5% of the company's publicly available shares short.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NEW YORK, Sept. 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 2seventy bio, Inc. ("2seventy bio" or the "Company") (NASDAQ: TSVT). Such investors are ...